Market Size -Veterinary renal disease refers to a range of conditions that affect the kidneys of animals, leading to impaired kidney function. It disrupts the kidneys' ability to filter waste, balance fluids, and produce certain hormones, leading to various health issues.Sizing and ForecastThe veterinary renal disease market size has grown strongly in recent years. It will grow from $14.55 billion in 2023 to $15.33 billion in 2024 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growing disease awareness initiatives, the shift in consumer preferences towards natural and organic pet food, increasing pet ownership rates globally, regulatory changes in veterinary pharmaceuticals, and growing awareness about pet health and nutrition.The veterinary renal disease market size is expected to see strong growth in the next few years. It will grow to $20.36 billion in 2028 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to the emergence of personalized veterinary medicine, expansion of telemedicine and remote monitoring in veterinary care, rise in veterinary clinical trials and research, adoption of blockchain technology for supply chain transparency in veterinary products, and integration of artificial intelligence and machine learning in veterinary diagnostics. Major trends in the forecast period include increasing demand for veterinary teleconsultations, the surge in customized pet nutrition plans, the growth of wearable health monitoring devices for pets, the expansion of veterinary telemedicine platforms, and the adoption of precision medicine in veterinary oncology.Order your report now for swift delivery, visit the link:https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-reportSegmentation & Regional InsightsThe veterinary renal disease market covered in this report is segmented -1) By Type: Diagnosis, Treatment2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications4) By Route of Administration: Injectable, Oral5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution ChannelsNorth America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:https://www.thebusinessresearchcompany.com/sample_request?id=15957&type=smpMajor Driver Impacting Market GrowthThe increased pet ownership is expected to propel the growth of the veterinary renal disease market going forward. Veterinary renal disease refers to conditions affecting the kidneys in animals, leading to impaired kidney function and potentially resulting in symptoms such as increased thirst, frequent urination, loss of appetite, and weight loss. The increasing veterinary renal disease is driven by longer pet lifespans, exposure to environmental toxins, dietary factors, and genetic predispositions. Veterinary renal disease treatments for pets typically involve dietary management, medication, and fluid therapy to alleviate symptoms, slow disease progression, and improve quality of life. For instance, in October 2022, according to Cooper Pet Care, a Netherlands-based mobile pet care platform, there will be approximately 145 million pet animals in the European Union, which includes Norway and Switzerland. This marks a rise of 5 million compared to the count in 2021, which stood at around 140 million pets. This population includes about 66 million dogs and 79 million cats. Therefore, increasing pet ownership is driving the growth of the veterinary renal disease market.Key Industry Players
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic
The veterinary renal disease market report table of contents includes:1. Executive Summary2. Veterinary Renal Disease Market Characteristics3. Veterinary Renal Disease Market Trends And Strategies4. Veterinary Renal Disease Market - Macro Economic Scenario5. Global Veterinary Renal Disease Market Size and Growth...31. Veterinary Renal Disease Market Other Major And Innovative Companies32. Global Veterinary Renal Disease Market Competitive Benchmarking33. Global Veterinary Renal Disease Market Competitive Dashboard34. Key Mergers And Acquisitions In The Veterinary Renal Disease Market35. Veterinary Renal Disease Market Future Outlook and Potential Analysis36.AppendixExplore the trending research reports from TBRC:Contact Us:The Business Research CompanyEurope: +44 207 1930 708Asia: +91 88972 63534Americas: +1 315 623 0293Email: info@tbrc.infoFollow Us On:LinkedIn: https://in.linkedin.com/company/the-business-research-companyTwitter: https://twitter.com/tbrc_infoFacebook: https://www.facebook.com/TheBusinessResearchCompanyYouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQBlog: https://blog.tbrc.info/Healthcare Blog: https://healthcareresearchreports.com/Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Renal Disease Market: Information by Disease Type (Chronic Kidney Disease and End-Stage Renal Disease (ESRD)), by Treatment Type (Dialysis, Medication and Kidney Transplantation), by End User (Dialysis Centers, Hospital & Clinics, and Research and Academic Institutes) and by Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027The global renal diseases market has been growing at an incremental pace and is expected to attain USD 14291.2 Mn by the end of 2023, reveals Market Research Future (MRFR) in a minutely analyzed research report.
These factors in conjunction will shape the global renal disease market and help it achieve a CAGR of 6.3% over the forecast period of 2017-2023.Request Free Sample Copy at:https://www.marketresearchfuture.com/sample_request/3167 SegmentationThe global renal disease market has been segmented based on type, diagnosis, and treatment.
By diagnosis, the market has been segmented into Blood tests, Urine tests, imaging tests, removing a sample of kidney tissue for testing, and others.
The blood tests segment has been further segmented into Serum Creatinine, Glomerular Filtration Rate (GFR), Blood Urea Nitrogen (BUN), and fasting blood glucose test.
The urine test segment has been further segmented into Urinalysis, Protein urine test, Microalbuminuria test, Creatinine Clearance test.
The medication segment has been further segmented into High blood pressure medications, Medications to lower cholesterol levels, Medications to treat anemia, Medications to relieve swelling, and Medications to protect your bones.
